High Response Rates With T-DXd in Early HER2-Low Breast Cancer High Response Rates With T-DXd in Early HER2-Low Breast Cancer

"The study provides a rich platform for additional translational research to evaluate more sensitive methods of HER2 detection."MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news